Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1Phase 1/2 1

Status

Active not recruiting 6Completed 5Withdrawn 3Terminated 3Recruiting 3Unknown 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5Gynecologic 2

Conditions

Ovarian Neoplasms 24Neoplasms 10Fallopian Tube Neoplasms 7Breast Neoplasms 5Prostatic Neoplasms 4Pancreatic Neoplasms 3Neoplasm Metastasis 2Mesothelioma 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Uveal Melanoma 1Uterine Neoplasms 1Urothelial Cancer 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Sarcoma, Ewing 1Recurrence 1Prostatic Diseases 1Prostate Carcinoma Metastatic to the Bone 1Prostate Adenocarcinoma 1Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1Pancreatic Adenocarcinoma 1Ovarian Diseases 1Mesothelioma, Malignant 1Melanoma 1Leukemia, Prolymphocytic, T-Cell 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × niraparib × Clear all
NCT04991480 2026-01-27

A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors

Artios Pharma Ltd

Phase 1 Completed
93 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03329937 2025-01-08

Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast Cancer

Tesaro, Inc.

Phase 1 Completed
21 enrolled 12 charts
Breast

Breast Neoplasms

NCT03154281 2024-08-01

Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Advanced Gynecologic Malignancies and Breast

Avera McKennan Hospital & University Health Center

Phase 1 Completed
14 enrolled 12 charts
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT04240106 2024-02-16

LUZERN

MedSIR

Phase 2 Completed
14 enrolled
Breast

Breast Neoplasms

NCT02657889 2022-12-01

TOPACIO

Tesaro, Inc.

Phase 1/2 Completed
122 enrolled 29 charts
BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Neoplasms, Ovarian Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡